BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10556640)

  • 1. Effects of leptin on fasting-induced inhibition of neuronal nitric oxide synthase mRNA in the paraventricular and supraoptic nuclei of rats.
    Isse T; Ueta Y; Serino R; Noguchi J; Yamamoto Y; Nomura M; Shibuya I; Lightman SL; Yamashita H
    Brain Res; 1999 Nov; 846(2):229-35. PubMed ID: 10556640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hypothalamic nitric oxide synthase gene expression in the rat paraventricular nucleus by food deprivation is independent of serotonin depletion.
    Ueta Y; Levy A; Chowdrey HS; Lightman SL
    J Neuroendocrinol; 1995 Nov; 7(11):861-5. PubMed ID: 8748123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct distribution and time-course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus following lipopolysaccharide injection.
    Harada S; Imaki T; Chikada N; Naruse M; Demura H
    Brain Res; 1999 Mar; 821(2):322-32. PubMed ID: 10064818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypovolemia upregulates the expression of neuronal nitric oxide synthase gene in the paraventricular and supraoptic nuclei of rats.
    Ueta Y; Levy A; Lightman SL; Hara Y; Serino R; Nomura M; Shibuya I; Hattori Y; Yamashita H
    Brain Res; 1998 Apr; 790(1-2):25-32. PubMed ID: 9593810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of hypothalamic neuronal nitric oxide synthase in lithium-induced diabetes insipidus rats.
    Anai H; Ueta Y; Serino R; Nomura M; Nakashima Y; Yamashita H
    Psychoneuroendocrinology; 2001 Feb; 26(2):109-20. PubMed ID: 11087959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebroventricular administration of alpha-melanocyte stimulating hormone increases phosphorylation of CREB in TRH- and CRH-producing neurons of the hypothalamic paraventricular nucleus.
    Sarkar S; Légrádi G; Lechan RM
    Brain Res; 2002 Jul; 945(1):50-9. PubMed ID: 12113951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids.
    Dong W; Seidel B; Marcinkiewicz M; Chrétien M; Seidah NG; Day R
    J Neurosci; 1997 Jan; 17(2):563-75. PubMed ID: 8987779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey.
    Roy BN; Reid RL; Van Vugt DA
    Endocrinology; 1999 May; 140(5):2191-8. PubMed ID: 10218971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of corticotropin-releasing hormone gene expression in the paraventricular nucleus of cyclophosphamide-induced cystitis in male rats.
    Mineta K; Nomura M; Terado M; Fujimoto N; Sasaguri T; Ueta Y; Matsumoto T
    Brain Res; 2004 Aug; 1018(2):193-200. PubMed ID: 15276878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of neuronal NOS mRNA in the PVN and SON of inherited diabetes insipidus rats.
    Yamamoto Y; Ueta Y; Nomura M; Serino R; Kabashima N; Shibuya I; Yamashita H
    Neuroreport; 1997 Dec; 8(18):3907-11. PubMed ID: 9462464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central administration of neuropeptide Y reduces alpha-melanocyte-stimulating hormone-induced cyclic adenosine 5'-monophosphate response element binding protein (CREB) phosphorylation in pro-thyrotropin-releasing hormone neurons and increases CREB phosphorylation in corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus.
    Sarkar S; Lechan RM
    Endocrinology; 2003 Jan; 144(1):281-91. PubMed ID: 12488356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of hypothalamic neuronal nitric oxide synthase and vasopressin in salt-loaded Dahl rat.
    Serino R; Ueta Y; Hanamiya M; Nomura M; Yamamoto Y; Yamaguchi KI; Nakashima Y; Yamashita H
    Auton Neurosci; 2001 Mar; 87(2-3):225-35. PubMed ID: 11476283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RU486 blocks fasting-induced decrease of neuronal nitric oxide synthase in the rat paraventricular nucleus.
    Kim YM; Lee JY; Choi SH; Kim DG; Jahng JW
    Brain Res; 2004 Aug; 1018(2):221-6. PubMed ID: 15276881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Melanocyte stimulating hormone prevents fasting-induced suppression of corticotropin-releasing hormone gene expression in the rat hypothalamic paraventricular nucleus.
    Fekete C; Légrádi G; Mihály E; Tatro JB; Rand WM; Lechan RM
    Neurosci Lett; 2000 Aug; 289(2):152-6. PubMed ID: 10904142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colocalization of urocortin and neuronal nitric oxide synthase in the hypothalamus and Edinger-Westphal nucleus of the rat.
    Spina MG; Langnaese K; Orlando GF; Horn TF; Rivier J; Vale WW; Wolf G; Engelmann M
    J Comp Neurol; 2004 Nov; 479(3):271-86. PubMed ID: 15457505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A defect of lipopolysaccharide-induced nitric oxide synthase gene expression in the paraventricular nucleus of Lewis rats.
    Chikada N; Imaki T; Harada S; Nakajima K; Naruse M; Yoshimoto T; Seki T; Tanabe A; Takano K
    Endocr J; 2000 Jun; 47(3):221-9. PubMed ID: 11036864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression.
    Fekete C; Légrádi G; Mihály E; Huang QH; Tatro JB; Rand WM; Emerson CH; Lechan RM
    J Neurosci; 2000 Feb; 20(4):1550-8. PubMed ID: 10662844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei.
    Nomura M; Ueta Y; Serino R; Yamamoto Y; Shibuya I; Yamashita H
    Neuroendocrinology; 1999 Mar; 69(3):167-80. PubMed ID: 10087449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of c-fos mRNA in the brain following intracerebroventricular injection of nitric oxide (NO)-releasing compounds: possible role of NO in central cardiovascular regulation.
    Chikada N; Imaki T; Seki T; Harada S; Nakajima K; Yoshimoto T; Naruse M; Demura H; Minami S; Takano K
    J Neuroendocrinol; 2000 Nov; 12(11):1112-23. PubMed ID: 11069127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.